AIIMS-led GRASSROOT trial proved India-made Supernova stent safe and effective for severe strokes, earning CDSCO approval. Lower-cost device could expand access to lifesaving thrombectomy nationwide.
The Supernova Stent is a new and advanced brain treatment device -- has been demonstrated to be safe and effective for stroke patients, said experts at AIIMS ...
The Food and Drug Administration (FDA) has granted 510(k) clearance for Vesalio’s enVast clot retriever, paving the way for ...
Vesalio, a leader in thrombectomy solutions, today announced FDA 510(k) clearance and the upcoming U.S. commercial launch of ...
Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, ...
Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous ...
The milestone reflects growing evidence for distal-specific thrombectomy solutions and is reinforced by interim findings that confirmed no safety concerns with TIGERTRIEVER 13. Rapid Medical, a ...
Rapid Medical completes DISTALS enrollment for TIGERTRIEVER 13 for DMVO stroke, backed by interim safety data and demand for distal-specific devices.
Rapid Medicaltm, a leading developer of active endovascular devices, announces the completion of patient enrollment in the DISTALS Trial, a multicenter randomized study assessing the TIGERTRIEVER 13tm ...
Rapid Medical announced the completion of patient enrollment in the multicenter, randomized DISTALS trial assessing the company ...
Investor's Business Daily on MSN
IBD stock of the day Penumbra lays the groundwork for 2026 acceleration
Penumbra is Friday's IBD Stock Of The Day following a strong third-quarter report and a "landmark" study vs. blood thinners.
Part of the money will go toward setting up a joint venture in Qatar, whose sovereign wealth fund led the round.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results